Invitation
Welcome to the 3rd Annual Skin Basics for Primary Care Conference
We are pleased to invite Primary Care Practitioners to join us for the 3rd Annual Skin Basics for Primary Care (SBPC) Conference, taking place in September 2026 at the Toronto Marriott Markham. This full-day program is designed specifically to support primary care clinicians looking to strengthen their dermatology knowledge and confidence.
Our faculty of expert dermatologists will cover essential fundamentals, practical approaches, and updates on new and emerging treatments relevant to everyday practice. Join us for an engaging day of learning, discussion, and skill-building as we explore the core elements of dermatologic care together.
We look forward to welcoming you and supporting your continued excellence in patient care.
Your Co-Chairs,
Dr. Patrick Fleming, BSc(Nutrition), MSc(Community Health), MD, FRCPC
Assistant Professor of Medicine, University of Toronto
Dermatologist & Investigator, York Dermatology & Research Centre
Consultant Dermatologist, University Health Network
Dr. Kyle O. Lee, BMLSc, BMBS, MPH, CCFP
Academic Family Physician, Sumac Creek Health Centre, St. Michael’s Hospital
Assistant Professor, Department of Family & Community Medicine, University of Toronto
Who Should Attend
- General practitioners
- Family physicians
- Pediatricians
- Nurse practitioners
- Physician assistants
- Pharmacists
- Medical trainees
September 19, 2026
Toronto Marriott Markham Markham, ON
The 3rd Annual SBPC Conference will take place at the Toronto Marriott Markham, a modern, upscale hotel located in the heart of Downtown Markham. The hotel’s contemporary meeting facilities provide an ideal setting for the SBPC, offering a comfortable and professional environment for learning and collaboration. Free parking is available to delegates driving in for the day.
Guests who wish to stay onsite may book accommodations directly with the hotel. A dedicated hotel booking link is provided for your convenience.
Address: 170 Enterprise Boulevard Markham, Ontario
Program
Saturday, September 19, 2026
Continuing Professional Development: this conference is an unaccredited activity.
The 2026 Program is currently under construction. Please check back soon for updates.
Registration
Registration will open in January 2026.
All fees are in Canadian dollars and subject to taxes of 13% HST. Registration includes continental breakfast, lunch and parking.
| REGULAR – to Sept 12 |
LATE – Sept 12 – 19 |
|
| Primary Care Practitioner | $90.00 | $130.00 |
| Industry Sponsor* | $265.00 | $370.00 |
*Sponsoring companies may purchase up to 2 additional registrations for representatives.
Cancellations and Refunds Policy
All registration fees will be refunded less a $20.00 + applicable taxes for refund requests received on or prior to August 21, 2026. No refunds will be available for cancellations received on or after August 22, 2026. All requests must be received in writing. No telephone cancellations will be accepted. Submit cancellation letters to the Conference Secretariat at the email noted above.
Questions?
If you have any questions, please contact the Conference Secretariat by email at [email protected] or by phone at (604) 738-8600.
Sponsors
.
If you are interested in becoming a 2026 sponsor and would like the opportunity to showcase your latest dermatological innovations to local primary care providers via a sponsored program session, please contact us for more information: [email protected]
We are grateful to the following organizations for their support of the 2nd Skin Basics for Primary Care in 2025.
2025 DIAMOND SPONSORS
Bausch Health Companies Inc. is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products, primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals, and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
More information can be found at the Company’s website.
Novartis is a focused innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.
In Canada, Novartis Pharmaceuticals Canada Inc. employs approximately 600 people to serve the evolving needs of patients and the healthcare system and invests over $30 million in R&D yearly in the country. Working together, we can reimagine medicine to improve and extend people’s lives.
2025 GOLD SPONSORS
AbbVie‘s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Arcutis Canada, Inc. is a wholly owned subsidiary of Arcutis Biotherapeutics. Arcutis Biotherapeutics champions innovation that addresses unmet patient needs—solving the everyday medical dermatology challenges that significantly impact patients and their families. With a passion for understanding what really matters to patients and healthcare providers, Arcutis leverages extensive dermatology development expertise to meaningfully advance the treatment of immune-mediated skin diseases. This expertise, along with Arcutis’ focus on biologically validated targets and its unique dermatology drug development platform prepares the company to tackle topical treatment innovation. Arcutis’ robust pipeline includes multiple development programs for a range of inflammatory dermatological conditions.
With the belief that patients deserve better than the current standard of care, the Arcutis team brings a sense of urgency, simplifying disease management and optimizing drug efficacy, safety, and tolerability to meet the needs of healthcare providers and patients. Arcutis has the potential to advance the standard of care for plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis.
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the U.S., and South America
Beiersdorf Canada is based in Saint-Laurent, Quebec. With our brands NIVEA, NIVEA MEN, Eucerin and Elastoplast we focus clearly on the needs of our consumers.
Beiersdorf Canada is one of more than 150 international affiliates of the cosmetics company Beiersdorf AG which is based in Hamburg, Germany. For over 130 years, we have dedicated ourselves to meeting our consumers’ individual needs and are considered to be the inventors of modern skin care. Our international success is founded on our research and development expertise, our innovative products, and our strong brands. Beiersdorf’s NIVEA is the world’s No.1 skin care brand*. Other names in its successful international brand portfolio include Eucerin, La Prairie, Labello, 8×4, and Hansaplast. Subsidiary tesa SE is one of the world’s leading producers of self-adhesive products and system solutions for industry, craft businesses, and consumers.
Galderma is the emerging pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market though Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. Galderma’s portfolio of flagship brands includes Dysport®, Restylane® and Sculptra® in Injectable Aesthetics; Aklief®, Apprilon®, Clobex®, Differin/XP®, MetroGel®, Metvix®, Onreltea®, Silkis®, TactuPump/TactuPump Forte®, Rosiver® and Benzac® in Therapeutic Dermatology; and Cetaphil®, Cetaphil Baby® and Alastin Skincare® in Dermatological Skincare. For more information, please visit: www.galderma.com
L’Oréal Dermatological Beauty’s mission is to help everyone in their quest for healthy and beautiful skin.
Our brands CeraVe, La Roche-Posay, SkinBetter, SkinCeuticals and Vichy, offer a broad range of options to address the health and beauty of everyone, everywhere.
2025 SILVER SPONSORS
